There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Sun Pharma with a price target of Rs 534 as against the current market price (CMP) of Rs 555 in its report dated Feb. 16, 2012. The broking house gave the following rationale: Sun Pharma has announced that in the on-going patent litigation on generic...
US-based Wyeth Pharmaceuticals has sought damages related to their ongoing patent dispute over a generic version of Protonix drug. Protonix is a registered trademark of Wyeth, which was acquired by Pfizer in 2009. In a regulatory filing issued after the...
Sun fell 2.8 percent to 541.15 rupees, poised for its steepest fall since Nov. 16, after declining as much as 3.9 percent at 11:40 a.m. in Mumbai. The stock was the biggest loser in the 19-company BSE Healthcare Index. (BSETHC) Sun and Teva...
Wednesday said Wyeth Pharmaceuticals Inc. is claiming damages of $960 million in a patent dispute over a generic version of the heartburn drug Protonix. Wyeth is a unit of Pfizer Inc. BANGALORE – India's Sun Pharmaceutical Industries Ltd. Wednesday...
Earlier in 2010, the District Court had denied defendants motion for judgment as a matter of law seeking to reverse the jury verdict that the patent is not invalid. The District Court is yet to rule on patent misuse. Wyeth`s experts have estimated the...
Wyeth, formerly known as American Home Products (AHP), is one of the largest pharmaceutical companies in the world. The company is based in Madison, New Jersey. They are known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast... Full Article
There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to Wyeth.
